BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Klingberg E, Magnusson MK, Strid H, Deminger A, Ståhl A, Sundin J, Simrén M, Carlsten H, Öhman L, Forsblad-d'Elia H. A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin. Arthritis Res Ther 2019;21:248. [PMID: 31771630 DOI: 10.1186/s13075-019-2018-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Ricciuto A, Sherman PM, Laxer RM. Gut microbiota in chronic inflammatory disorders: A focus on pediatric inflammatory bowel diseases and juvenile idiopathic arthritis. Clinical Immunology 2020;215:108415. [DOI: 10.1016/j.clim.2020.108415] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
2 Koszewicz M, Mulak A, Dziadkowiak E, Budrewicz S. Is Fecal Calprotectin an Applicable Biomarker of Gut Immune System Activation in Chronic Inflammatory Demyelinating Polyneuropathy? - A Pilot Study. Front Hum Neurosci 2021;15:733070. [PMID: 34867240 DOI: 10.3389/fnhum.2021.733070] [Reference Citation Analysis]
3 So J, Tam LS. Gut Microbiome and Its Interaction with Immune System in Spondyloarthritis. Microorganisms 2020;8:E1727. [PMID: 33158167 DOI: 10.3390/microorganisms8111727] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Liao H, Tsai C, Lai C, Hsieh S, Sun Y, Li K, Shen C, Wu C, Lu C, Kuo Y, Li T, Chou C, Yu C. The Potential Role of Genetics, Environmental Factors, and Gut Dysbiosis in the Aberrant Non-Coding RNA Expression to Mediate Inflammation and Osteoclastogenic/Osteogenic Differentiation in Ankylosing Spondylitis. Front Cell Dev Biol 2022;9:748063. [DOI: 10.3389/fcell.2021.748063] [Reference Citation Analysis]
5 Yang KL, Lejeune A, Chang G, Scher JU, Koralov SB. Microbial-derived antigens and metabolites in spondyloarthritis. Semin Immunopathol 2021;43:163-72. [PMID: 33569635 DOI: 10.1007/s00281-021-00844-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wang L, Wang Y, Zhang P, Song C, Pan F, Li G, Peng L, Yang Y, Wei Z, Huang F. Gut microbiota changes in patients with spondyloarthritis: A systematic review. Semin Arthritis Rheum 2021:S0049-0172(21)00198-0. [PMID: 34844732 DOI: 10.1016/j.semarthrit.2021.11.002] [Reference Citation Analysis]
7 Brereton NJB, Pitre FE, Gonzalez E. Reanalysis of the Mars500 experiment reveals common gut microbiome alterations in astronauts induced by long-duration confinement. Comput Struct Biotechnol J 2021;19:2223-35. [PMID: 33995915 DOI: 10.1016/j.csbj.2021.03.040] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Hwang MC, Ridley L, Reveille JD. Ankylosing spondylitis risk factors: a systematic literature review. Clin Rheumatol 2021;40:3079-93. [PMID: 33754220 DOI: 10.1007/s10067-021-05679-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Rademacher J, Poddubnyy D, Pleyer U. Uveitis in spondyloarthritis. Ther Adv Musculoskelet Dis 2020;12:1759720X20951733. [PMID: 32963592 DOI: 10.1177/1759720X20951733] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Cardoneanu A, Cozma S, Rezus C, Petrariu F, Burlui AM, Rezus E. Characteristics of the intestinal microbiome in ankylosing spondylitis. Exp Ther Med 2021;22:676. [PMID: 33986841 DOI: 10.3892/etm.2021.10108] [Reference Citation Analysis]
11 Sandionigi A, De Giani A, Tursi F, Michelotti A, Cestone E, Giardina S, Zampolli J, Di Gennaro P, Abbassi MS. Effectiveness of Multistrain Probiotic Formulation on Common Infectious Disease Symptoms and Gut Microbiota Modulation in Flu-Vaccinated Healthy Elderly Subjects. BioMed Research International 2022;2022:1-16. [DOI: 10.1155/2022/3860896] [Reference Citation Analysis]
12 Mangalam AK, Yadav M, Yadav R. The Emerging World of Microbiome in Autoimmune Disorders: Opportunities and Challenges. Indian J Rheumatol 2021;16:57-72. [PMID: 34531642 DOI: 10.4103/injr.injr_210_20] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Mauro D, Thomas R, Guggino G, Lories R, Brown MA, Ciccia F. Ankylosing spondylitis: an autoimmune or autoinflammatory disease? Nat Rev Rheumatol 2021;17:387-404. [PMID: 34113018 DOI: 10.1038/s41584-021-00625-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Feng HY, Chan CH, Chu YC, Qu XM, Wang YH, Wei JC. Patients with ankylosing spondylitis have high risk of irritable bowel syndrome. A long-term nationwide population-based cohort study. Postgrad Med 2022. [PMID: 35139724 DOI: 10.1080/00325481.2022.2041338] [Reference Citation Analysis]
15 Magro F, Estevinho MM. Is Faecal Calprotectin Important in Detecting Silent Gut Inflammation in Seronegative Arthropathies? J Crohns Colitis 2020;14:886-7. [PMID: 32016384 DOI: 10.1093/ecco-jcc/jjaa011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Fisher C, Ciurtin C, Leandro M, Sen D, Wedderburn LR. Similarities and Differences Between Juvenile and Adult Spondyloarthropathies. Front Med (Lausanne) 2021;8:681621. [PMID: 34136509 DOI: 10.3389/fmed.2021.681621] [Reference Citation Analysis]
17 Harkins P, Burke E, Swales C, Silman A. 'All disease begins in the gut'-the role of the intestinal microbiome in ankylosing spondylitis. Rheumatol Adv Pract 2021;5:rkab063. [PMID: 34557624 DOI: 10.1093/rap/rkab063] [Reference Citation Analysis]
18 Underwood MA, Mukhopadhyay S, Lakshminrusimha S, Bevins CL. Neonatal intestinal dysbiosis. J Perinatol 2020;40:1597-608. [PMID: 32968220 DOI: 10.1038/s41372-020-00829-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
19 Sagard J, Olofsson T, Mogard E, Marsal J, Andréasson K, Geijer M, Kristensen LE, Lindqvist E, Wallman JK. Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritis. Arthritis Res Ther 2022;24. [DOI: 10.1186/s13075-022-02733-w] [Reference Citation Analysis]
20 Chan S, Morrison M, Hawley CM, Campbell SB, Francis RS, Isbel NM, Pascoe EM, Johnson DW. Characteristics of the gastrointestinal microbiota in paired live kidney donors and recipients. Nephrology (Carlton) 2021;26:471-8. [PMID: 33501716 DOI: 10.1111/nep.13853] [Reference Citation Analysis]
21 Berthelot JM, Darrieutort-Laffite C, Trang C, Maugars Y, Le Goff B. Contribution of mycobiota to the pathogenesis of spondyloarthritis. Joint Bone Spine 2021;88:105245. [PMID: 34166798 DOI: 10.1016/j.jbspin.2021.105245] [Reference Citation Analysis]
22 Wang X, Wang J, Guo W, Zhou Y, Sun C, Li Z, Chen L, Pan X. [Characteristics of intestinal flora in patients with primary Sjögren syndrome]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:949-57. [PMID: 32895147 DOI: 10.12122/j.issn.1673-4254.2020.07.06] [Reference Citation Analysis]
23 Ercalik C, Baskaya MC, Ozdem S, Butun B. Investigation of asymptomatic intestinal inflammation in ankylosing spondylitis by fecal calprotectin. Arab J Gastroenterol 2021:S1687-1979(21)00042-3. [PMID: 34531137 DOI: 10.1016/j.ajg.2021.05.020] [Reference Citation Analysis]
24 Scalise G, Ciancio A, Mauro D, Ciccia F. Intestinal Microbial Metabolites in Ankylosing Spondylitis. J Clin Med 2021;10:3354. [PMID: 34362137 DOI: 10.3390/jcm10153354] [Reference Citation Analysis]